Allergovac depot

BIOLOGICAL2 trials

Sponsors

Roxall Medicina España S.A

Conditions

Allergic Rhinoconjunctivitis

Phase 2

Dose-response Study With Subcutaneous Immunotherapy of an Standardized Dermatophagoides Pteronyssinus (DPT) Extract

CompletedNCT01564017

Roxall Medicina España S.AAllergic Rhinoconjunctivitis

Start: 2012-05-31End: 2013-05-31Updated: 2017-05-01

Phase II Trial With Subcutaneous Immunotherapy in Patients Sensitized to Phleum Pratense

CompletedNCT01567306

Roxall Medicina España S.AAllergic Rhinoconjunctivitis

Start: 2011-10-31End: 2013-04-30Updated: 2019-04-29